» Articles » PMID: 3595566

Tissue-specific Expression of the Human Growth Hormone Gene is Conferred in Part by the Binding of a Specific Trans-acting Factor

Overview
Journal EMBO J
Date 1987 Apr 1
PMID 3595566
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

The molecular basis for the pituitary-specific expression of the human growth hormone (hGH) gene was investigated, by gene transfer and protein footprinting experiments. Plasmid constructs in which CAT or Neo transcription units are fused to a 0.5 kb fragment of the hGH 5' sequences were efficiently expressed in GC and GH3 cells, derived from a pituitary tumor, but not in cell lines of other origins, indicating the presence of a tissue-specific promoter. DNaseI footprinting experiments have identified at least three factors that specifically bind to the hGH 5' region. While two of these factors were also detected in extracts of non-expressing cells, the third factor, GHF-1, was detected only in extracts of GH expressing pituitary tumor cells. Mutagenesis experiments suggest that binding of GHF-1 and some of the other more ubiquitous factors is required for optimal hGH promoter activity in vivo. Tissue specificity of the hGH promoter therefore seems to be determined by the binding of at least one tissue-specific trans-acting factor, acting in concert with several other more ubiquitous, yet specific, DNA binding proteins.

Citing Articles

HMGA1B/2 transcriptionally activated-POU1F1 facilitates gastric carcinoma metastasis via CXCL12/CXCR4 axis-mediated macrophage polarization.

Tang C, Lei X, Xiong L, Hu Z, Tang B Cell Death Dis. 2021; 12(5):422.

PMID: 33927188 PMC: 8084942. DOI: 10.1038/s41419-021-03703-x.


POU1F1 transcription factor induces metabolic reprogramming and breast cancer progression via LDHA regulation.

Martinez-Ordonez A, Seoane S, Avila L, Eiro N, Macia M, Arias E Oncogene. 2021; 40(15):2725-2740.

PMID: 33714987 PMC: 8049871. DOI: 10.1038/s41388-021-01740-6.


Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.

Martinez-Ordonez A, Seoane S, Cabezas P, Eiro N, Sendon-Lago J, Macia M Oncogene. 2018; 37(11):1430-1444.

PMID: 29321662 DOI: 10.1038/s41388-017-0036-8.


Associations of POU1F1 gene polymorphisms and protein structure changes with growth traits and blood metabolites in two Iranian sheep breeds.

Sadeghi M, Jalil-Sarghale A, Moradi-Shahrbabak M J Genet. 2015; 93(3):831-5.

PMID: 25572243 DOI: 10.1007/s12041-014-0438-0.


Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13.

Sendon-Lago J, Seoane S, Eiro N, Bermudez M, Macia M, Garcia-Caballero T Breast Cancer Res. 2014; 16(6):505.

PMID: 25527274 PMC: 4305241. DOI: 10.1186/s13058-014-0505-8.


References
1.
Graham F, Van Der Eb A . A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973; 52(2):456-67. DOI: 10.1016/0042-6822(73)90341-3. View

2.
Moore D, Marks A, Buckley D, Kapler G, Payvar F, Goodman H . The first intron of the human growth hormone gene contains a binding site for glucocorticoid receptor. Proc Natl Acad Sci U S A. 1985; 82(3):699-702. PMC: 397113. DOI: 10.1073/pnas.82.3.699. View

3.
Galas D, Schmitz A . DNAse footprinting: a simple method for the detection of protein-DNA binding specificity. Nucleic Acids Res. 1978; 5(9):3157-70. PMC: 342238. DOI: 10.1093/nar/5.9.3157. View

4.
Davison B, Leighton T, RABINOWITZ J . Purification of Bacillus subtilis RNA polymerase with heparin-agarose. In vitro transcription of phi 29 DNA. J Biol Chem. 1979; 254(18):9220-6. View

5.
Benoist C, OHare K, Breathnach R, Chambon P . The ovalbumin gene-sequence of putative control regions. Nucleic Acids Res. 1980; 8(1):127-42. PMC: 327247. DOI: 10.1093/nar/8.1.127. View